03/28/2025
3:53 PM | Aadi Bioscience (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2025
7:21 AM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
3:38 PM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
8:29 AM | Aadi Bioscience (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/11/2025
6:22 PM | Aadi Bioscience (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
03/10/2025
3:30 PM | Aadi Bioscience (Subject)
ABG Management Ltd. (Filed by)
| Form SCHEDULE 13G | |
03/06/2025
4:55 PM | Aadi Bioscience (Subject)
Desai Neil (Filed by)
| Form SCHEDULE 13D/A | |
03/05/2025
6:51 PM | Aadi Bioscience (Issuer)
Dalal Anupam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
2:58 PM | Aadi Bioscience (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/04/2025
6:24 PM | Aadi Bioscience (Issuer)
Castelein Caley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:09 PM | Aadi Bioscience (Issuer)
BALL BRYAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AADI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aadi Bioscience and its competitors with MarketBeat's FREE daily newsletter. |
03/04/2025
5:11 PM | Aadi Bioscience (Issuer)
Dornan David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:14 PM | Aadi Bioscience (Issuer)
Zhao Baiteng (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:56 PM | Aadi Bioscience (Issuer)
Aghazadeh Behzad (Reporting)
Avoro Capital Advisors LLC (Reporting)
Avoro Ventures LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:58 PM | Aadi Bioscience (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SCHEDULE 13D/A | |
03/03/2025
7:34 PM | Aadi Bioscience (Subject)
Giacobello Scott M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
7:36 PM | Aadi Bioscience (Subject)
Lennon David James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
7:37 PM | Aadi Bioscience (Issuer)
Lennon David James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:38 PM | Aadi Bioscience (Issuer)
Giacobello Scott M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:31 PM | Aadi Bioscience (Subject)
BALL BRYAN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
10:38 AM | Aadi Bioscience (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
02/19/2025
4:08 PM | Aadi Bioscience (Filer)
| Form DEFA14A | |
02/14/2025
1:00 PM | Aadi Bioscience (Subject)
QVT Financial LP (Filed by)
| Form SCHEDULE 13G | |
02/14/2025
11:11 AM | Aadi Bioscience (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
10:11 AM | Aadi Bioscience (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
01/31/2025
4:09 PM | Aadi Bioscience (Filer)
| Form DEFM14A | |
01/30/2025
2:32 PM | Aadi Bioscience (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D | |
01/29/2025
6:01 PM | Aadi Bioscience (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
01/24/2025
1:34 PM | Aadi Bioscience (Subject)
ACUTA CAPITAL PARTNERS, LLC (Filed by)
| Form SCHEDULE 13D/A | |
01/21/2025
3:54 PM | Aadi Bioscience (Filer)
| Form PREM14A | |
12/31/2024
10:13 AM | Aadi Bioscience (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D | |
12/30/2024
4:04 PM | Aadi Bioscience (Filer)
| Form DEFA14A | |
12/23/2024
4:34 PM | Aadi Bioscience (Issuer)
Zhao Baiteng (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/23/2024
4:36 PM | Aadi Bioscience (Issuer)
Zhao Baiteng (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
4:26 PM | Aadi Bioscience (Subject)
Desai Neil (Filed by)
| Form SCHEDULE 13D/A | |
12/23/2024
2:51 PM | Aadi Bioscience (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SCHEDULE 13D/A | |
12/20/2024
5:05 AM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
5:08 AM | Aadi Bioscience (Filer)
| Form DEFA14A | |
11/06/2024
3:08 PM | Aadi Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:05 AM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
6:01 PM | Aadi Bioscience (Subject)
Lennon David James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Elon Musk is helping print “new gold” (Ad) MIT scientists just developed a brand-new metal…
A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology.
It’s so valuable that some are referring to it as the “new gold”. I reveal all of the details here. |
10/03/2024
6:03 PM | Aadi Bioscience (Issuer)
Lennon David James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:35 PM | Aadi Bioscience (Subject)
Desai Neil (Filed by)
| Form SC 13D/A | |
09/30/2024
5:06 AM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:13 PM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
4:55 PM | Aadi Bioscience (Issuer)
Desai Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:51 PM | Aadi Bioscience (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
09/03/2024
9:40 AM | Aadi Bioscience (Subject)
Desai Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:42 PM | Aadi Bioscience (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
08/22/2024
3:15 PM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
8:21 PM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:16 PM | Aadi Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
7:02 AM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
5:49 PM | Aadi Bioscience (Issuer)
Desai Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:37 PM | Aadi Bioscience (Issuer)
Desai Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:18 PM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:25 PM | Aadi Bioscience (Issuer)
Desai Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:26 AM | Aadi Bioscience (Subject)
Desai Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
7:07 AM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
3:05 PM | Aadi Bioscience (Filer)
| Form 424B5 | |
05/01/2024
7:50 PM | Aadi Bioscience (Issuer)
Desai Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
11:15 PM | Aadi Bioscience (Filer)
| Form EFFECT | |
04/26/2024
3:50 PM | Aadi Bioscience (Issuer)
BALL BRYAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/26/2024
3:56 PM | Aadi Bioscience (Filer)
| Form ARS | |
04/26/2024
1:33 PM | Aadi Bioscience (Filer)
| Form DEFA14A | |
04/26/2024
1:31 PM | Aadi Bioscience (Filer)
| Form DEF 14A | |
04/04/2024
3:08 PM | Aadi Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
